Préda I, Sebeszta M, Antalóczy Z
Arzneimittelforschung. 1980;30(3):436-8.
The influence of potassium-canrenoate (Aldactone) on the noradrenaline (NA) uptake and metabolism of the heart was studied in normal and hypopotassemic rats. The administration to normal rats resulted in a marked increase of 3H-NA uptake both in the atrial and ventricular tissues, but the NA content was unchanged. An increased NA uptake of myocardium in the presence of an unchanged content suggested an increased rate of NA turnover under the influence of the drug. In saluretic pretreated animals the substance normalized both the previously decreased NA uptake and the low intracellular potassium level of the heart tissue. The augmentation of catecholamine metabolism due to the drug may be involved in an enhanced activity of adenyl cyclase and form the basis of the positive inotropic effect of the compound.
在正常和低钾血症大鼠中研究了安体舒通对心脏去甲肾上腺素(NA)摄取和代谢的影响。给正常大鼠给药后,心房和心室组织中3H-NA摄取显著增加,但NA含量未变。在含量不变的情况下心肌对NA摄取增加表明在药物影响下NA周转速率增加。在进行过促尿钠排泄预处理的动物中,该物质使先前降低的NA摄取和心脏组织细胞内低钾水平均恢复正常。该药物引起的儿茶酚胺代谢增强可能与腺苷酸环化酶活性增强有关,并构成该化合物正性肌力作用的基础。